Tag Archives: Innovation

5 questions about hand sanitizer answered

AUGUSTA, Ga. – Hand sanitizers are more popular than ever – and so are myths about the products.

We get a lot of questions about hand sanitizers and their uses. Are they safe? Are they effective?” said Dr. Stephen Hsu, a Georgia Regents University researcher with a growing line of green tea products.

His start-up biotechnology and drug development company Camellix, LLC, uses green tea-derived technologies to treat dry mouth, dandruff, and cold sores with natural ingredients. Now, Hsu has turned his attention to creating a better hand sanitizer and lotion using compounds derived from green tea.

“People have come to expect that they can use a hand sanitizer to help protect themselves during cold and flu season,” said Hsu, Professor of Oral Biology, Oral Health & Diagnostic Sciences in the GRU College of Dental Medicine. “That’s true, but in reality, hand sanitizers have so much more potential.”

Hsu’s ProtecTeaV® EGCG Hand Sanitizer and EGCG Skin Lotion use a modified epigallocatechin-3-gallate (EGCG) compound derived from green tea because it’s got the potential to protect against an extensive range of deadly or debilitating viruses. The new hand sanitizer and lotion are available in pharmacies and online starting this summer. Here, Hsu tackles five common myths about hand sanitizers:

Myth #1: Hand sanitizers only prevent colds.

“Studies in a number of research journals show us that EGCG protects human cells from infection of HIV, herpes, norovirus, hepatitis B and C viruses, human papilloma virus, even Ebola, according to recently published antiviral research by the U.S. Army Medical Research Institute of Infectious Diseases ,” said Hsu, a recipient of the 2015 Georgia Bio Innovation Award. “The significance of this technology is the potential to save thousands, if not tens of thousands, of lives from a variety of viral infections.”

As a result of the research, Camellix plans to donate shipments of its new EGCG sanitizer and lotion to military personnel fighting the spread of Ebola in West Africa.

Myth #2: Hand sanitizers replace hand washing.

“Soap and water are still the best way to clean the skin. When they’re not available, hand sanitizers are a great option,” Hsu said. “Sanitizers work best when your hands aren’t overly dirty or greasy, so if it’s possible, you always want to wash or wipe down your hands first to remove visible grime.”

Myth # 3: All hand sanitizers are created equally.

Most sanitizers kill bacteria and some viruses with alcohol, which evaporates in about 20 seconds. “This is fine for immediate cleansing if applied correctly, but it is temporary,” Hsu said. “The key is to provide a long-lasting barrier against viruses. The unique ProtecTeaV® formulation provides a 2-hour barrier by combining alcohol with lipophilic EGCG, a compound patented by Georgia Regents University.”

Myth # 4: Sanitizers kill all bacteria and viruses.

Most bacteria can be killed by alcohol-based sanitizers, but in order to effectively kill viruses, the concentration of alcohol must be very high, or about 90 percent,, which is dangerously flammable.

“With norovirus, for example, the US Centers for Disease Control and Prevention recommends washing hands with soap and water frequently to prevent infection instead of relying solely on alcohol-based sanitizers,” Hsu said. “The rabies and polio viruses are also resistant to alcohol. Compounds to kill these alcohol-resistant viruses are urgently needed. We believe EGCG, especially lipophilic EGCG, is an excellent candidate.”

Myth #5: There is no wrong way to use hand sanitizer.

“The sanitizer can’t do its job if it isn’t applied properly,” Hsu said. “Put a nickel-sized dollop of the product in the palm of one hand and rub hands together, until the surface of your hands and fingers are coated. Keep rubbing until dry. For the best results, wash and dry your hands before using hand sanitizer, then follow with lotion.”

About Dr. Stephen Hsu

Dr. Stephen Hsu, Professor of Oral Biology, Oral Health & Diagnostic Sciences in the College of Dental Medicine at Georgia Regents University, earned a bachelor’s degree in biochemistry from Wuhan University after a six-year forced labor experience in a rural farm in China.

After moving to the United States, he earned a Master of Arts degree in molecular biology from Montclair State University in New Jersey and a Ph.D. in cell biology and anatomy from the University of Cincinnati College of Medicine.

Dr. Stephen Hsu is founder of Camellix, LLC, which develops and markets products using green tea-derived technologies to treat dry mouth, dandruff, cold sores, and viral infections with natural ingredients. The products were developed and patented in the Georgia Regents University Life Sciences Business Development Center in the Office of Innovation Commercialization. Hsu joined GRU 1999 and serves as Course Director for both Nutrition and Biochemistry courses. He has joint appointments in the Institute of Molecular Medicine and Genetics, GRU Cancer Center, and VA Medical Center Augusta.

More information

Learn more about ProtecTeaV® EGCG Hand Sanitizer and Skin Lotion at www.camellix.com or the GRU Office of Innovation Commercialization at www.gru.edu/oic.

 

 

 

In the news: Two from GRU to receive Innovation Awards from Georgia Bio

ATLANTA–(BUSINESS WIRE)–Georgia Bio today announced recipients for the Innovation Award. The Innovation Award will be presented to EndoChoice, Inc. for their Fuse-Full Spectrum Endoscopy technology; Stephen Hsu, Ph.D. of Camellix, LLC; Leonard Reeves, MD, FAAFP of Georgia Regents University; and Tom Robertson of Cogent Education.

[Read more…]

Final days to register for Innovation Summit

Two innovators who lead top high-tech companies will headline our second annual Innovation Summit on Tuesday, Oct. 7, from 8 a.m. to 6 p.m. at the Salvation Army Kroc Center, 1833 Broad St. Dr. Dirk Brown, founder of Pandoodle, a digital technology company, is the summit’s keynote speaker. His presentation, “The Pandoodle Story,” will begin at 9:30 a.m.; and Dr. Mimi Healy, CEO of LaserGen, a biotechnology company focused on commercializing new technologies for DNA sequencing, will speak about “Serial Entrepreneurship – Scraped Knuckles and Bruises … and Fun,” during lunch at 12:15 p.m. To register and see the full schedule, please visit gru.edu/oic/is14

Innovation Summit program, speakers announced

AUGUSTA, Ga. – Two innovators who lead top high-tech companies will headline Georgia Regents University’s second annual Innovation Summit on Tuesday, Oct. 7, from 8 a.m. to 6 p.m. at the Salvation Army Kroc Center, 1833 Broad St.

Dirk Brown headshotDr. Dirk Brown, founder of Pandoodle, a digital technology company, is the summit’s keynote speaker. His presentation, “The Pandoodle Story,” will begin at 9:30 a.m.; and Dr. Mimi Healy, CEO of LaserGen, a biotechnology company focused on commercializing new technologies for DNA sequencing, will speak about “Serial Entrepreneurship – Scraped Knuckles and Bruises … and Fun,” during lunch at 12:15 p.m.

A seasoned executive with a strong track record of developing, marketing, and licensing disruptive, proprietary technologies, Brown founded Pandoodle Corporation in 2008, and it has grown to include offices in California, New York, and South Carolina. The company focuses on native advertising, an online advertising method that allows the advertiser to get attention by adapting to the user’s experience, with the overall intent of making paid advertisements feel less intrusive and increasing the likelihood someone will click on it.

Brown also serves as the Director of the Faber Entrepreneurship Center and is a faculty member at both the Darla Moore School of Business and the College of Engineering and Computing at the University of South Carolina. He holds more than 25 patents and has written more than 30 technical papers and journal articles.

Mimi Healy headshotHealy, who was named CEO of LaserGen in 2012, has served in roles in research and development, commercialization, and executive management in both startup and established organizations and has more than 20 years of health care, molecular diagnostics, and biotechnology experience in both U.S. and international markets. Her expertise includes strategic development and implementation, corporate finance and fundraising, and product development, from research to the clinical validation and successful market launch of molecular diagnostic systems and test kits.

The Innovation Summit also will feature “short takes” from the following innovators and creative thinkers:

  • Dr. Richard Schwartz, Chairman of the Department of Emergency Medicine in the Medical College of Georgia, who created and marketed an abdominal aortic tourniquet, which has been called a game-changer because it helps save soldiers with the most common cause of preventable death in combat: a traumatic pelvic wound.
  • Candice and Aaron Hark, who founded Maxient, an online system that enables easier information-sharing between university student conduct offices.
  • Pete Mourfield, Director of Software Engineering for TaxSlayer, which develops financial software for consumers and financial professionals.
  • Howard Merry, of NEBA Health, a new type of ADHD test approved by the FDA. NEBA is the first medical device based on brain function that can help assess ADHD in children and adolescents.

The day will end with a “shark tank” featuring innovation pitches, followed by a mocktail reception.

Fully sponsored by GRU’s Office of Innovation Commercialization and James M. Hull College of Business, as well as the Savannah River National Laboratory, the goal of the summit is to help turn good ideas into great products and services.

For the complete agenda, or to register, visit gru.edu/oic/is14. For more information, contact Chris McKinney in the Office of Innovation Commercialization at 706-721-4062 or Christopher.McKinney@gru.edu.

 

 

 

Innovation Summit registration begins

Make plans to attend the 2014 Innovation Summit on Tuesday, Oct. 7, at the Salvation Army Kroc Center, 1833 Broad St., and learn how to turn good ideas into great products and services.

The conference, fully sponsored by the GRU Office of Innovation Commercialization, the James M. Hull College of Business, and Savannah River National Laboratory, will feature distinguished speakers who will share strategies, trends, and practical advice. Attendees can learn new ways to think about the future and network with industry colleagues and leading innovators.

To register and view the developing agenda, visit gru.edu/oic/is14. For more information, call or email Chris McKinney in the Office of Innovation Commercialization, christopher.mckinney@gru.edu or 706-721-4062.

 

Dr. Mark Hamrick to resume academic duties in research

Dr. Mark W. Hamrick has resigned his role as Senior Vice President for Research effective Sept. 1 and will return to the Department of Cellular Biology & Anatomy to focus on research into bone biology.

“While it is a loss for us to lose Mark in this administrative role, we are grateful that his contributions to GRU’s research enterprise will continue,” said Dr. Gretchen B. Caughman, Executive Vice President for Academic Affairs and Provost. “He has worked tirelessly to advance research at GRU, and his accomplishments have included overhauling the intramural grants program, launching the Institute for Regenerative & Reparative Medicine, and organizing the first Augusta Research Symposium on Advances in Warrior Care. Mark is an outstanding colleague, and I look forward to his continued scientific contributions.”

Dr. Michael Diamond, Vice President of Clinical and Translational Sciences and Chair of the Department of Obstetrics and Gynecology at the Medical College of Georgia, will serve as Interim Senior Vice President for Research.

Hamrick became Interim Vice President for Research in 2010 and was named to the position permanently in 2011. His research in improving bone strength is funded by the National Institutes of Health and the U.S. Department of the Army.

As Senior Vice President for Research, he oversees all aspects of the university’s research enterprise, including developing a strategic plan to advance GRU’s goals related to sponsored research programs.

Hamrick received GRU’s 2009 Innovation in Teaching Award, 2009 and 2010 Exemplary Teaching Awards, and 2005 Outstanding Young Faculty Award in Basic Sciences. In his role at GRU, he has also provided administrative oversight to implement the new electronic platforms for research administration and recruited new leadership in the Office of Innovation Commercialization, clinical research, and Laboratory Animal Services.  He developed new research communications, Research Impact and GResearch, with the Office of Communications and Marketing, and established new, collaborative research partnerships with the Savannah River National Lab and Georgia Tech.

“I am grateful for the opportunity to have led one of this university’s most critical missions,” Hamrick said. “It has been an honor to serve the hundreds of scientists here, who I truly believe are making a significant impact and lessening the burden of illness on our society with their important work.”

OIC Lunch ‘n Learn: From Drug Idea to Clinical Proof of Concept

The Office of Innovation Commercialization will hold its quarterly Lunch ‘n Learn on Tuesday, Oct. 1, from noon-1 p.m. in the Interdisciplinary Research Building (CA), room 2109, on the Health Sciences Campus.

“From Drug Idea to Clinical Proof of Concept” will be presented by Michele Luche, Technical Director of Drug Discovery at Albany Molecular Research Inc. Luche will share her real-life story of how she helped move a new drug through part of the FDA process.

Luche has more than 24 years of experience in drug discovery, which includes working on programs focused specifically on oncology, inflammation, CNS disorders, and infectious disease. Previously, she served as Director of Assay Development and High Throughput Screening at CEPTYR Inc. and Head of High Throughput Screening Operations at SUGEN Inc., where she was a key contributor in the development of the marketed drug SUTENT, a kinase inhibitor.

RSVP by Tuesday, Sept. 24 by contacting Sandra Jackson at 706-721-0153 or sanjackson@gru.edu.

 

Experts motivate community to be innovative

Innovation SummitThe Kroc Center was filled with early morning greetings and smiles as the Innovation Summit registrants grabbed a quick bite before heading to the theatre to hear keynote speaker Diego Olego, Senior Vice President and Chief Strategy and Innovation Officer for Philips Healthcare.

“There is a definite buzz, a sense of creativity. This is a great time to be in Augusta and to be a part of Georgia Regents University,” said Mark Hamrick, GRU’s Senior Vice President for Research.

Olego addressed “Accelerating Time to Market Globally” by giving attendees the four key innovation intersections: discipline, core competencies, public/private partnerships for localized solutions, and rapid prototyping.

Throughout his talk, Olego stressed the importance of innovation in the health care market. “We need to make sure we invent, we innovate. We need to make sure we provide the best economic outcome,” he said.

More than 300 people registered for the two-day affair that was filled with networking, exhibits, panel discussions, and presentations by experts in the fields of journalism, business, and health care.

Inaugural Innovation Summit planned for Sept. 17-18

Register for the Innovation SummitSharing strategies, trends, and practical advice to help turn innovative ideas into exciting products, services, and companies will be the focus of the inaugural Innovation Summit Sept. 17-18 at the Salvation Army Kroc Center.

The free conference will feature successful entrepreneurs and thought leaders in innovation sharing their strategies, tips, and lessons learned to help move good ideas into viable products, said Georgia Regents University Associate Vice President for Innovation Commercialization Chris McKinney.

Keynote speakers for the summit are:

  • Dr. Diego Olego, Senior Vice President and Chief Strategy & Innovation Officer at Philips Healthcare, who will talk about “Accelerating Time to Market Globally.” Olego joined Philips in 1986 and leads innovation strategy, technology investments, and research directions for its medical division.  At Philips Research, he has managed technology programs and research projects in solid state electronics, displays, software development, and medical instrumentation for new products spanning the breadth of Philips businesses.
  • Jordan Eisenberg, Founder and President of UrgentRx, maker of single-dose foil packets of flavored, powdered over-the-counter medications that can be taken without water and can be found at check-out counters at 2,700 retailers across the country. Eisenberg, whose company expects to see more than $3 million in revenue this year, will share his experiences as a serial entrepreneur. He has experience in manufacturing and production, sales and marketing, public relations, and strategic planning, with an affinity for high growth companies.
  • Amy Cortese, an award-winning journalist and editor, will speak about crowd-sourced fundraising (crowdfunding) and local investing in innovation commercialization. Cortese covers topics spanning business, finance, food, wine and environmental issues, and her work has been featured in the New York Times, New York Times Magazine, New York, Business Week, the Daily News, and The American. Her book, “Locavesting: The Revolution in Local Investing and How to Profit From It,” draws upon her experience covering those topics and how a small shift in investment – away from multinationals toward locally owned enterprises – can reap enormous economic and social benefits.

GRU’s Office of Innovation Commercialization, Hull College of Business, and the Savannah River National Laboratory are sponsoring the event, which will also feature opportunities to network with policymakers, investors, economic development partners, colleagues, and other professionals interested in innovation. For a full conference agenda, visit gru.edu/oic/is13/

Register now for the Innovation Summit

innovationsummitartDistinguished speakers in thought leadership will share strategies, trends, and practical advice at the 2013 Innovation Summit, Sept. 17-18. This free, two-day event will be held at the Kroc Center.

The summit, sponsored by the Office of Innovation Commercialization, will provide attendees with information on new ideas and technologies that can be used in creating efficient and practical operations for their organizations.

Keynote speakers will be Diego Olego, Senior Vice President and Chief Strategy and Innovation Officer for Philips Healthcare; Jordan Eisenberg, founder and CEO of UrgenRx; and Amy Cortese, a journalist, editor, and author of the book “Locavesting: The Revolution in Local Investing and How to Profit From It.”

“We’ve got a great collection of speakers to challenge us, panels to help us think about new ways to bring innovations to the market, and exhibits to show us how to take those critical next steps,” GRU’s Associate Vice President for Innovation Commercialization Chris McKinney said. “Much like the overall summit, our keynote speakers touch on a variety of different subjects. There is really something for everyone here, from small business entrepreneurs in a local market to companies that want to make a global impact.”

Registrants will be able to attend all keynote and plenary sessions and the “Shark Tank” pitches and panel discussion.  It also includes admission to breakfasts, lunch, and reception; coffee and refreshment breaks; access to exhibits; and on-site wireless internet. Registration for this free event is now open, and space is limited. To register online, go to www.gru.edu/oic/is13/registration.php.

For a complete listing of sessions, exhibits, and speakers, go to www.gru.edu/oic/is13.